{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:47Z","timestamp":1792785047834,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zabol University of Medical Sciences","id":[{"id":"https:\/\/ror.org\/037tr0b92","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59627-z","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:06:09Z","timestamp":1782745569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Principal component analysis of adipokine, metabolic, oxidative, and inflammatory markers associated with insulin resistance in metabolic syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Soudabeh","family":"Hamedi-Shahraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Amirkhizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-0996","authenticated-orcid":false,"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"3","key":"59627_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/ijms27031237","volume":"27","author":"E Gusev","year":"2026","unstructured":"Gusev, E., Sarapultsev, A. & Zhuravleva, Y. Insulin Resistance and Inflammation. Int. J. Mol. Sci. 27 (3), 1237 (2026).","journal-title":"Int. J. Mol. Sci."},{"key":"59627_CR2","doi-asserted-by":"publisher","first-page":"1397836","DOI":"10.3389\/fendo.2024.1397836","volume":"15","author":"A Klisic","year":"2024","unstructured":"Klisic, A., Patoulias, D. & Isenovic, E. R. Editorial: Oxidative stress and inflammation in cardiometabolic disorders. Front. Endocrinol. 15, 1397836 (2024).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"59627_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12902-025-02142-5","volume":"26","author":"S Hamedi-Shahraki","year":"2026","unstructured":"Hamedi-Shahraki, S., Klisic, A., Amirkhizi, F. & Mercantepe, F. Association of the triglyceride-glucose index with inflammatory markers and dysregulation of adipokines in patients with metabolic syndrome. BMC Endocr. Disorders. 26 (1), 44 (2026).","journal-title":"BMC Endocr. Disorders"},{"issue":"2","key":"59627_CR4","first-page":"602","volume":"22","author":"A Klisic","year":"2026","unstructured":"Klisic, A., Toma\u0161evi\u0107, R., Djuraskovic, S., Mercantepe, F. & Ninic, A. Biomarkers for the early identification of metabolic dysfunction-associated steatotic liver disease (MASLD) \u2013 A narrative review. Arch. Med. Sci. 22 (2), 602\u2013641 (2026).","journal-title":"Arch. Med. Sci."},{"key":"59627_CR5","doi-asserted-by":"publisher","first-page":"1374584","DOI":"10.3389\/fendo.2024.1374584","volume":"15","author":"A Klisic","year":"2024","unstructured":"Klisic, A. et al. The Role of Oxidative Stress in Metabolic and Inflammatory Diseases. Front. Endocrinol. 15, 1374584 (2024).","journal-title":"Front. Endocrinol."},{"issue":"10","key":"59627_CR6","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/biomedicines13102321","volume":"13","author":"WJS Pedro","year":"2025","unstructured":"Pedro, W. J. S. et al. Freitas J\u00fanior WR. Role of Adipokines Chemerin, Visfatin, and Omentin in Obesity and Their Inflammatory and Metabolic Implications. Biomedicines 13 (10), 2321 (2025).","journal-title":"Biomedicines"},{"issue":"6","key":"59627_CR7","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/ijms27062558","volume":"27","author":"DD Mitroi Sakizlian","year":"2026","unstructured":"Mitroi Sakizlian, D. D. et al. Circulating Adiponectin and Omentin Across Cardiometabolic Phenotypes: Links to Atherogenic Indices in Prediabetes and New-Onset Type 2 Diabetes. Int. J. Mol. Sci. 27 (6), 2558 (2026).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"59627_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3390\/biomedicines13112619","volume":"13","author":"DT Yilmaz","year":"2025","unstructured":"Yilmaz, D. T., Gul, M. A., Capraz, M., Demir, H. D. & Tekcan, A. Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers. Biomedicines 13 (11), 2619 (2025).","journal-title":"Biomedicines"},{"issue":"4","key":"59627_CR9","first-page":"987","volume":"19","author":"A Klisic","year":"2021","unstructured":"Klisic, A., Kavaric, N., Kotur, J. & Ninic, A. Serum soluble transferrin receptor levels are independently associated with homeostasis model assessment of insulin resistance in adolescent girls. Arch Med Sci 19(4), 987\u2013994 (2021).","journal-title":"Arch Med Sci"},{"key":"59627_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-026-02140-0","volume":"18","author":"S Hamedi-Shahraki","year":"2026","unstructured":"Hamedi-Shahraki, S., Mercantepe, F., Amirkhizi, F. & Klisic, A. Clustering adipokines, metabolic, oxidative stress, and inflammatory markers associated with cardiovascular disease risk in patients with metabolic syndrome. Diabetol Metab Syndr 18, 100 (2026).","journal-title":"Diabetol Metab Syndr"},{"issue":"15","key":"59627_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157650","volume":"26","author":"A Klisic","year":"2025","unstructured":"Klisic, A. et al. Relationship Between Oxidative Stress and Cardiovascular Risk in Adolescents in Montenegro. Int J Mol Sci 26(15), 7650 (2025).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"59627_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12902-022-01141-0","volume":"22","author":"Z Khademi","year":"2022","unstructured":"Khademi, Z., Hamedi-Shahraki, S. & Amirkhizi, F. Vitamin D insufficiency is associated with inflammation and deregulation of adipokines in patients with metabolic syndrome. BMC Endocr. Disord. 22 (1), 223 (2022).","journal-title":"BMC Endocr. Disord"},{"key":"59627_CR13","doi-asserted-by":"crossref","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120(16), 1640-5 (2009).","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"5","key":"59627_CR14","first-page":"426","volume":"13","author":"F Azizi","year":"2010","unstructured":"Azizi, F. et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch. Iran. Med. 13 (5), 426\u2013428 (2010).","journal-title":"Arch. Iran. Med."},{"issue":"7","key":"59627_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412\u20139 (1985).","journal-title":"Diabetologia"},{"issue":"7","key":"59627_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/03007995.2025.2545489","volume":"41","author":"S Bah\u00e7eba\u015f\u0131","year":"2025","unstructured":"Bah\u00e7eba\u015f\u0131, S., A\u00e7maz, B., Ayd\u0131n, E., Bi\u00e7er, \u0130\u0130 & Y\u0131ld\u0131z, \u015e. Sex-specific clinical and inflammatory predictors of insulin resistance in individuals living with obesity: a retrospective analysis of 1,457 adults. Curr Med Res Opin 41(7), 1197\u20131206 (2025).","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"59627_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15040494","volume":"15","author":"A Samavarchitehrani","year":"2025","unstructured":"Samavarchitehrani, A., Mercantepe, F., Behnoush, A. H. & Klisic, A. Exploring the TyG Index and the Homeostasis Model Assessment of Insulin Resistance as Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding-A Narrative Review. Diagnostics (Basel) 15(4), 494 (2025).","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"59627_CR18","first-page":"1073","volume":"18","author":"MB Moghaddam","year":"2012","unstructured":"Moghaddam, M. B. et al. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl. Sci. J. 18 (8), 1073\u20131080 (2012).","journal-title":"World Appl. Sci. J."},{"key":"59627_CR19","unstructured":"National Center for Health Statistics. NHIS Adult Tobacco Use Glossary. Centers for Disease Control and Prevention. (2024). Available from: https:\/\/archive.cdc.gov\/#\/details?q=current%20smokers&start=0&rows=10&url=https:\/\/www.cdc.gov\/nchs\/nhis\/tobacco\/tobacco_recodes.htm"},{"issue":"12","key":"59627_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel, O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38(12), 1103\u201311 (2005).","journal-title":"Clin Biochem"},{"key":"59627_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","volume":"299","author":"IF Benzie","year":"1999","unstructured":"Benzie, I. F. & Strain, J. J. Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 299, 15\u201327 (1999).","journal-title":"Methods Enzymol."},{"issue":"9","key":"59627_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/met.2024.0100","volume":"22","author":"A Klisic","year":"2024","unstructured":"Klisic, A., Karakasis, P., Patoulias, D., Khalaji, A. & Nini\u0107, A. Are Oxidative Stress Biomarkers Reliable Part of Multimarker Panel in Female Patients with Type 2 Diabetes Mellitus?. Metab Syndr Relat Disord 22(9), 679\u2013685 (2024).","journal-title":"Metab Syndr Relat Disord"},{"key":"59627_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.18794\/aams\/186748","volume":"78","author":"K Stocerz","year":"2024","unstructured":"Stocerz, K. et al. Selected adipokines as potential prognostic and diagnostic agents in treatment of metabolic disorders associated with obesity. Annales Academiae Medicae Silesiensis 78, 138\u2013145 (2024).","journal-title":"Annales Academiae Medicae Silesiensis"},{"key":"59627_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biom15050612","volume":"15","author":"S Datta","year":"2025","unstructured":"Datta, S., Koka, S. & Boini, K. M. Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge. Biomolecules 15, 612 (2025).","journal-title":"Biomolecules"},{"issue":"6","key":"59627_CR25","doi-asserted-by":"publisher","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","volume":"290","author":"RZ Yang","year":"2006","unstructured":"Yang, R. Z. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290(6), E1253-61 (2006).","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"59627_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/biomedicines13030632","volume":"13","author":"HM Biega\u0144ski","year":"2025","unstructured":"Biega\u0144ski, H. M., D\u0105browski, K. M. & R\u00f3\u017ca\u0144ska-Wal\u0119dziak, A. Omentin-General Overview of Its Role in Obesity, Metabolic Syndrome and Other Diseases; Problem of Current Research State. Biomedicines 13 (3), 632 (2025).","journal-title":"Biomedicines"},{"issue":"1","key":"59627_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/cvr\/cvw016","volume":"110","author":"K Watanabe","year":"2016","unstructured":"Watanabe, K. et al. Counteractive effects of omentin-1 against atherogenesis. Cardiovasc. Res. 110 (1), 118\u2013128 (2016).","journal-title":"Cardiovasc. Res."},{"key":"59627_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.imlet.2018.01.008","volume":"196","author":"V Gupta","year":"2018","unstructured":"Gupta, V., Mishra, S., Mishra, S., Kumar, S. & Gupta, V. Association of leptin: adiponectin ratio and metabolic risk markers in postmenopausal women. Immunol Lett 196, 63\u20137 (2018).","journal-title":"Immunol Lett"},{"key":"59627_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116104","volume":"222","author":"L Xie","year":"2024","unstructured":"Xie, L., Wang, H., Hu, J., Liu, Z. & Hu, F. The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs ): Connections and interactions in liver diseases. Biochem Pharmacol 222, 116104 (2024).","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"59627_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75409-x","volume":"14","author":"A Klisic","year":"2024","unstructured":"Klisic, A., Kotur-Stevuljevic, J., Gluscevic, S., Sahin, S. B. & Mercantepe, F. Biochemical markers and carotid intima-media thickness in relation to cardiovascular risk in young women. Sci Rep 14(1), 24776 (2024).","journal-title":"Sci Rep"},{"issue":"5","key":"59627_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4093\/dmj.2011.35.5.523","volume":"35","author":"FO Gunduz","year":"2011","unstructured":"Gunduz, F. O. et al. Serum visfatin and fetuin-a levels and glycemic control in patients with obese type 2 diabetes mellitus. Diabetes Metab. J. 35 (5), 523\u2013528 (2011).","journal-title":"Diabetes Metab. J."},{"issue":"5","key":"59627_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-2265.2007.02966.x","volume":"67","author":"K Oki","year":"2007","unstructured":"Oki, K., Yamane, K., Kamei, N., Nojima, H. & Kohno, N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 67(5), 796\u2013800 (2007).","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"59627_CR33","first-page":"18","volume":"13","author":"HA Al Doghaither","year":"2019","unstructured":"Al Doghaither, H. A. et al. Insulin resistance and its correlation with chemerin and visfatin in Saudi patients with hyperthyroidism. Int. J. Health Sci. (Qassim). 13 (5), 18\u201321 (2019).","journal-title":"Int. J. Health Sci. (Qassim)"},{"issue":"4","key":"59627_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/13813455.2025.2486290","volume":"131","author":"AA Sherly","year":"2025","unstructured":"Sherly, A. A., Rukmini, M. S., Hegde, A., Arun, S. & Kotian, H. Serum levels of omentin and visfatin in patients with metabolic syndrome. Arch. Physiol. Biochem. 131 (4), 683\u2013690 (2025).","journal-title":"Arch. Physiol. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59627-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:07:48Z","timestamp":1790291268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59627-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59627"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59627-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed in accordance with the declaration of Helsinki and Zabol University of Medical Sciences ethical guidelines and regulations. The research protocol was approved by the Zabol University of Medical Sciences (Ethics No: IR.ZBMU.REC.1405.028). All participants signed a written inform consent before participating in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence (AI) tools were used solely for improving the academic English language and clarity of the manuscript. No AI tools were used for data analysis, interpretation of results, or generation of scientific content. All scientific content, analysis, and interpretation were performed solely by the authors.","order":3,"name":"Ethics","label":"AI use","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29806"}}